CBP-1019
Oncology (vs. TOP1 inhibitor ADCs)
Phase 1/2Active
Key Facts
About Coherent Biopharma
A clinical-stage biotech company developing bi-targeting XDC drugs to treat cancer and address undruggable targets.
View full company profileOncology (vs. TOP1 inhibitor ADCs)
A clinical-stage biotech company developing bi-targeting XDC drugs to treat cancer and address undruggable targets.
View full company profile